EP0726775A4 - Vaccine and method for treatment of chlamydial infections - Google Patents

Vaccine and method for treatment of chlamydial infections

Info

Publication number
EP0726775A4
EP0726775A4 EP95902425A EP95902425A EP0726775A4 EP 0726775 A4 EP0726775 A4 EP 0726775A4 EP 95902425 A EP95902425 A EP 95902425A EP 95902425 A EP95902425 A EP 95902425A EP 0726775 A4 EP0726775 A4 EP 0726775A4
Authority
EP
European Patent Office
Prior art keywords
vaccine
treatment
chlamydial infections
chlamydial
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95902425A
Other languages
German (de)
French (fr)
Other versions
EP0726775A1 (en
Inventor
Marta Iris Sabara
James Evan Sandbulte
Julie Ann Terwee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of EP0726775A1 publication Critical patent/EP0726775A1/en
Publication of EP0726775A4 publication Critical patent/EP0726775A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP95902425A 1993-11-03 1994-11-02 Vaccine and method for treatment of chlamydial infections Withdrawn EP0726775A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14763693A 1993-11-03 1993-11-03
US147636 1993-11-03
PCT/US1994/012626 WO1995012411A1 (en) 1993-11-03 1994-11-02 Vaccine and method for treatment of chlamydial infections

Publications (2)

Publication Number Publication Date
EP0726775A1 EP0726775A1 (en) 1996-08-21
EP0726775A4 true EP0726775A4 (en) 1999-03-31

Family

ID=22522314

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95902425A Withdrawn EP0726775A4 (en) 1993-11-03 1994-11-02 Vaccine and method for treatment of chlamydial infections

Country Status (7)

Country Link
EP (1) EP0726775A4 (en)
CN (1) CN1134112A (en)
AU (1) AU701247B2 (en)
BR (1) BR9407986A (en)
CA (1) CA2175081A1 (en)
NZ (1) NZ276874A (en)
WO (1) WO1995012411A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184132C (en) * 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US5972350A (en) * 1996-05-06 1999-10-26 Bayer Corporation Feline vaccines containing Chlamydia psittaci and method for making the same
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
EP1108033A2 (en) * 1998-07-27 2001-06-20 Aventis Pasteur Limited $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
WO2000034498A1 (en) * 1998-12-04 2000-06-15 University Of Manitoba Two-step immunization procedure against chlamydia infection
CA2395499C (en) 1999-12-22 2011-10-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU2138501A (en) * 1999-12-22 2001-07-03 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2138601A (en) * 1999-12-22 2001-07-03 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
ES2386386T3 (en) * 2001-12-12 2012-08-20 Novartis Vaccines And Diagnostics S.R.L. Immunization against Chlamydia trachomatis
ES2788728T3 (en) 2010-05-28 2020-10-22 Spixia Biotechnology Ab Chimeric MOMP antigen, method and use
ES2900757T3 (en) 2015-02-10 2022-03-18 Ohio State Innovation Foundation Chlamydia-activated B cell platforms and methods thereof
CA3004924A1 (en) * 2015-11-10 2017-05-18 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271146A (en) * 1979-09-06 1981-06-02 Seawell Albert C Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
POOLMAN J T ET AL: "Second generation meningococcal OMP - LPS vaccines.", NIPH ANNALS, (1991 DEC) 14 (2) 233-41. JOURNAL CODE: N7E. ISSN: 0332-5652., Norway, XP002091566 *
SANDBULTE J ET AL: "Evaluation of Chlamydia psittaci subfraction and subunit preparations for their protective capacities.", VETERINARY MICROBIOLOGY, (1996 FEB) 48 (3-4) 269-82. JOURNAL CODE: XBW. ISSN: 0378-1135., Netherlands, XP002091565 *
See also references of WO9512411A1 *

Also Published As

Publication number Publication date
WO1995012411A1 (en) 1995-05-11
BR9407986A (en) 1996-12-03
CN1134112A (en) 1996-10-23
EP0726775A1 (en) 1996-08-21
CA2175081A1 (en) 1995-05-11
AU701247B2 (en) 1999-01-21
AU1129795A (en) 1995-05-23
NZ276874A (en) 1997-11-24

Similar Documents

Publication Publication Date Title
CS149192A3 (en) Pharmaceutical composition, process of its preparation and method offungal infections treating
PL316007A1 (en) Vaccine based on urease and method of treating infections caused by heliobacter
BR9407799A (en) Composition of matter treatment method and pharmaceutical composition
AU1875692A (en) Exhaust treatment system and method
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
EP0758242A4 (en) Composition and method for treatment of cmv infection
IL102092A0 (en) Vaccine and treatment method for human immunodeficiency virus
EP0726775A4 (en) Vaccine and method for treatment of chlamydial infections
GB9218027D0 (en) Novel method of treatment
GB9202196D0 (en) Method of treatment
ZA938897B (en) Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
ZW11693A1 (en) Method of treating viral infections
GB9201391D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
GB9319897D0 (en) Method for the treatment and shaping of hair
IL108749A0 (en) Selective treatment of enteroviral-caused infections in humans
AU3286893A (en) Therapeutic device and method of treatment
GB9307004D0 (en) Method of treatment
GB9321796D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment
MW8393A1 (en) Method of treating viral infections
ZA936559B (en) Method of treating viral infections
IL104735A0 (en) Apparatus and method of treating blood
GB9207275D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990216

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990831

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000111